Compounds suitable for treatment of haemophilia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9125890
APP PUB NO 20140018297A1
SERIAL NO

13916262

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to Von Willebrand (VWF) compounds as well as compositions suitable for treatment of blood clotting diseases. The present invention also relates to pharmaceutical compositions, freeze-dried or liquid, comprising (i) a Factor VIII molecule and (ii) a VWF compound.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVO NORDISK A/S2880 BAGSVAERD

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bolt, Gert Vaerloese, DK 20 72
Haaning, Jesper Birkeroed, DK 11 102
Hansen, Jens Jacob Jyllinge, DK 9 179
Karpf, Ditte Maria Veskoe Sjaelland, DK 5 25
Kjalke, Marianne Frederikssund, DK 17 91
Olsen, Ole Hvilsted Broenshoej, DK 68 771
Petersen, Maj Bagsvaerd, DK 7 13
Rischel, Christian Copenhagen S, DK 9 42
Rode, Frederik Hedehusene, DK 7 13
Roepstorff, Kirstine Bagsvaerd, DK 7 13
Thim, Lars Gentofte, DK 56 471

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00